Patrick J. Jansen

Implications of In-Use Photostability: Proposed Guidance for Photostability Testing and Labeling to Support the Administration of Photosensitive Pharmaceutical Products, Part 1: Drug Products Administered by Injection

Steven W. Baertschi, David Clapham, Chris Foti et al. · Journal of Pharmaceutical Sciences · 2013 · 52 citations

Part 1, In-use Photostability, Photochemistry +12

Characterization of Impurities Formed by Interaction of Duloxetine HCl with Enteric Polymers Hydroxypropyl Methylcellulose Acetate Succinate and Hydroxypropyl Methylcellulose Phthalate

Patrick J. Jansen, Peter L. Oren, Craig A. J. Kemp et al. · Journal of Pharmaceutical Sciences · 1998 · 50 citations

Determination of relative UV response factors for HPLC by use of a chemiluminescent nitrogen-specific detector

Mark A. Nussbaum, Steven W. Baertschi, Patrick J. Jansen · Journal of Pharmaceutical and Biomedical Analysis · 2002 · 49 citations

Chemiluminescent Nitrogen-specific Detector, Biochemistry, Photochemistry +11

Recent Trends in Product Development and Regulatory Issues on Impurities in Active Pharmaceutical Ingredient (API) and Drug Products. Part 2: Safety Considerations of Impurities in Pharmaceutical Products and Surveying the Impurity Landscape

Karen M. Alsante, Kim Huynh‐Ba, Steven W. Baertschi et al. · AAPS PharmSciTech · 2013 · 41 citations · Full text

Impurity Landscape, Regulatory Issues, Chemical Engineering +11

Isolation, Identification, and Synthesis of Two Oxidative Degradation Products of Olanzapine (LY170053) in Solid Oral Formulations

Steven W. Baertschi, Heiko Brunner, Charles A. Bunnell et al. · Journal of Pharmaceutical Sciences · 2007 · 24 citations

Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Science +11